Fidelity Management and Research Company

Type

Corporate investor

Status

Active

Location

Boston, United States

Total investments

392

Average round size

276M

Portfolio companies

300

Rounds per year

5.09

Lead investments

36

Follow on index

0.21

Exits

126

Stages of investment
Private EquityLate Stage Venture
Areas of investment
BiotechnologyTransportationSoftwareInformation TechnologyHealth CareManufacturingMedicalLife SciencePharmaceuticalTherapeutics

Summary

Fidelity Management and Research Company appeared to be the VC, which was created in 1946. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Boston.

Considering the real fund results, this VC is 16 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2018. Opposing the other organizations, this Fidelity Management and Research Company works on 12 percentage points more the average amount of lead investments. The typical startup value when the investment from Fidelity Management and Research Company is more than 1 billion dollars. The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of more than 100 millions dollars.

The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Fidelity Management and Research Company, startups are often financed by Atlas Venture, Venrock, The Column Group. The meaningful sponsors for the fund in investment in the same round are Invus, Wellington Management, Redmile Group. In the next rounds fund is usually obtained by ARCH Venture Partners, EcoR1 Capital, T. Rowe Price.

Among the most popular portfolio startups of the fund, we may highlight Lyft, Moderna Therapeutics, Magic Leap. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Pharmaceutical, Medical Device. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The overall number of key employees were 2.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
392
Lead investments
36
Exits
126
Rounds per year
5.09
Follow on index
0.21
Investments by industry
  • Biotechnology (140)
  • Health Care (100)
  • Medical (66)
  • Software (59)
  • Therapeutics (51)
  • Show 270 more
Investments by region
  • United States (316)
  • Singapore (1)
  • United Kingdom (12)
  • India (7)
  • Canada (14)
  • Show 14 more
Peak activity year
2021
Number of Unicorns
79
Number of Decacorns
96
Number of Minotaurs
60

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
2B
Group Appearance index
0.96
Avg. company exit year
10
Avg. multiplicator
1.86
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
AgomAb Therapeutics 11 Oct 2023 Biotechnology, Health Care, Therapeutics Late Stage Venture 111M East Flanders, Ghent, Belgium
Apogee Therapeutics 07 Dec 2022 Biotechnology, Medical, Life Science, Therapeutics Early Stage Venture 149M United States, California, San Francisco
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.